Workshop participants composed of key officials from the DA National Laboratories, Regional Integrated Laboratories (Regions II, III, VII, and XI), Dr Pierre Gavard (center), and BAFS Personnel at Holiday Hills Hotel, Ortigas, Pasig City (February 8-9, 2017).

A two-day Seminar Workshop on the Development of a National Monitoring Plan and Preparation of Laboratory Project Documents was spearheaded by the Bureau of Agriculture and Fisheries Standards through the current EU-TRTA III Project held at the Holiday Inn Hotel, Ortigas Pasig City last February 8-9, 2017.  Officers and representatives from the DA Central Office, Laboratories and Regional Integrated Laboratories were present during the workshop.

Ms. Lara V. Navarro, OIC-Chief of the Standards Development Division of BAFS, introduced the last mission of Dr. Pierre Gavard, Short Term Expert of the EU TRTA III Project, and gave a short background of the past workshop under the EU TRTA III Project. She also presented the activities of the workshop: first day was intended for the development of the laboratory project document while the second day was for the monitoring plan organization and proficiency testing implementation and coordination on risk assessment procedures and monitoring plan between DA and FDA.

Also present during the activity was BAFS Director Karen S. Bautista who expressed her gratitude to all participants for their strong support and cooperation on the last activity under the EU TRTA III Project Evaluation of Laboratories of the Department of Agriculture and Proposed Laboratory Policy.  Director Bautista stressed the importance of the activity on the Development of Laboratory Project Document based on the Laboratory Inventory Submission requested from participating agencies and the Monitoring Plan Organization and Proficiency Testing Documents aligned towards obtaining a harmonized approach to make full-use of the DA laboratory services.

Consequently, Dr. Pierre Gavard discussed his presentations covering the topics of the workshop which included: (1) development of laboratory project document for DA and FDA laboratories, (2) monitoring plan organization and proficiency testing implementation; and (3) coordination on risk assessment procedures and monitoring plan between DA and FDA.